BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8635096)

  • 1. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labeling indices.
    Oka K; Nakano T; Hoshi T
    Cancer; 1996 Jun; 77(11):2280-5. PubMed ID: 8635096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High growth fraction at 9 grays of radiotherapy is associated with a good prognosis for patients with cervical squamous cell carcinoma.
    Oka K; Suzuki Y; Nakano T
    Cancer; 2000 Oct; 89(7):1526-31. PubMed ID: 11013367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
    Yu CC; Dublin EA; Camplejohn RS; Levison DA
    Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma.
    Lam KY; Law SY; So MK; Fok M; Ma LT; Wong J
    Cancer; 1996 Jan; 77(1):7-13. PubMed ID: 8630942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activity.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; de Nictolis M; Muzzioli M; Fabris N; Romanini C; Biagini G
    Gynecol Oncol; 1995 Jul; 58(1):28-33. PubMed ID: 7789886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of proliferation index with MIB-1 as a prognostic factor in radiation therapy for cervical cancer.
    Suzuki M; Tsukagoshi S; Saga Y; Ohwada M; Sato I
    Gynecol Oncol; 2000 Nov; 79(2):300-4. PubMed ID: 11063661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract.
    Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; Kagawa S
    Cancer; 1996 Aug; 78(4):827-33. PubMed ID: 8756378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image cytometric comparison of proliferating cell nuclear antigen and MIB-1 staining in hepatocellular carcinoma and adjacent liver tissue.
    Wells SJ; DeRose PB; Cohen C
    Cytometry; 1996 Sep; 26(3):198-203. PubMed ID: 8889391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of serum and immunohistochemical expression of SCC and CA19-9 in radiation therapy for cervical cancer.
    Abe A; Nakano T; Morita S; Oka K
    Anticancer Res; 1999; 19(1B):829-36. PubMed ID: 10216501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIB-1 labeling index as a prognostic indicator for survival in patients with FIGO stage IB squamous cell carcinoma of the cervix.
    Ho DM; Hsu CY; Chiang H
    Gynecol Oncol; 2000 Jan; 76(1):97-102. PubMed ID: 10620448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient increases of growth fraction during fractionated radiation therapy for cervical carcinoma. Ki-67 and PC10 immunostaining.
    Oka K; Nakano T; Hoshi T
    Cancer; 1993 Nov; 72(9):2621-7. PubMed ID: 8402484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of proliferation-associated antigens in cervical carcinoma: correlations among indexes.
    Oka K; Nakano T; Arai T
    Pathol Res Pract; 1995 Oct; 191(10):997-1003. PubMed ID: 8838367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
    Markiewski M; Domagała W
    Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
    Hille A; Weiss E; Hess CF
    Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
    Lee CS
    Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 overexpression in primary hypopharyngeal carcinomas.
    Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S
    Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The comparison of radiosensitivity between uterine cervical squamous carcinoma and adenocarcinoma].
    Zhang M; Cai S; Shi D
    Zhonghua Fu Chan Ke Za Zhi; 1998 Oct; 33(10):611-3. PubMed ID: 10806688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
    Veronese SM; Maisano C; Scibilia J
    Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.
    Cattoretti G; Becker MH; Key G; Duchrow M; Schlüter C; Galle J; Gerdes J
    J Pathol; 1992 Dec; 168(4):357-63. PubMed ID: 1484317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.